Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
09 Novembro 2023 - 8:58PM
Business Wire
Cencora, Inc. (NYSE: COR), formerly AmerisourceBergen
Corporation, today announced that it has agreed to repurchase
shares of its common stock from Walgreens Boots Alliance Holdings
LLC in the amount of approximately $250 million in concurrence with
Walgreens Boots Alliance’s entry into certain variable pre-paid
forward transactions executed in reliance on Rule 144 under the
Securities Act of 1933, as amended.
Cencora intends to repurchase shares from Walgreens Boots
Alliance at the per share price equal to the price in the Rule 144
transaction. The concurrent share repurchase will be made under
Cencora’s share repurchase program and the repurchased shares will
be held in treasury.
About Cencora
Cencora is a leading global pharmaceutical solutions
organization centered on improving the lives of people and animals
around the world. We partner with pharmaceutical innovators across
the value chain to facilitate and optimize market access to
therapies. Care providers depend on us for the secure, reliable
delivery of pharmaceuticals, healthcare products, and solutions.
Our 46,000+ worldwide team members contribute to positive health
outcomes through the power of our purpose: We are united in our
responsibility to create healthier futures. Cencora is ranked #11
on the Fortune 500 and #24 on the Global Fortune 500 with more than
$250 billion in annual revenue. Learn more at
www.investor.cencora.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231109249889/en/
Bennett S. Murphy Senior Vice President, Head of
Investor Relations & Treasury 610-727-3693
Bennett.Murphy@cencora.com
Cencora (NYSE:COR)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Cencora (NYSE:COR)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024